Literature DB >> 21469145

Tangled fibroblasts in tumor-stroma interactions.

Min Liu1, Jingjing Xu, Hong Deng.   

Abstract

Fibrogenesis, expressed as "desmoplasia," is found in many kinds of tumors and considered to be associated with malignancy. In fact, fibroblasts in cancer stroma have attracted considerable attention in the last 2 decades. Although it is accepted that fibroblasts are important in tumor development and progression, the mechanisms involved are highly complex and difficult to disentangle. Which role do fibroblasts play in tumors-are they friends or foes? Can fibroblasts account for the relationship between inflammation, fibrosis and tumor? Do fibroblasts acquire gene changes during carcinogenesis and how many signaling pathways are involved in tumor-stroma interactions? What is the outcome of fibroblast activation in tumors-senescence, death or recovery to a progenitor cell such as the fibrocyte? These questions still need further exploration and will be discussed in this review.
Copyright © 2011 UICC.

Entities:  

Mesh:

Year:  2011        PMID: 21469145     DOI: 10.1002/ijc.26116

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

1.  Ormeloxifene suppresses desmoplasia and enhances sensitivity of gemcitabine in pancreatic cancer.

Authors:  Sheema Khan; Mara C Ebeling; Neeraj Chauhan; Paul A Thompson; Rishi K Gara; Aditya Ganju; Murali M Yallapu; Stephen W Behrman; Haotian Zhao; Nadeem Zafar; Man Mohan Singh; Meena Jaggi; Subhash C Chauhan
Journal:  Cancer Res       Date:  2015-04-03       Impact factor: 12.701

2.  Intratumor stromal proportion predicts aggressive phenotype of gastric signet ring cell carcinomas.

Authors:  Dakeun Lee; In-Hye Ham; Sang Yong Son; Sang-Uk Han; Young-Bae Kim; Hoon Hur
Journal:  Gastric Cancer       Date:  2016-11-17       Impact factor: 7.370

3.  Tumor-associated mesothelial cells are negative prognostic factors in gastric cancer and promote peritoneal dissemination of adherent gastric cancer cells by chemotaxis.

Authors:  Zhi-Feng Miao; Ting-Ting Zhao; Zhen-Ning Wang; Feng Miao; Ying-Ying Xu; Xiao-Yun Mao; Jian Gao; Hui-Mian Xu
Journal:  Tumour Biol       Date:  2014-03-11

4.  Model of vascular desmoplastic multispecies tumor growth.

Authors:  Chin F Ng; Hermann B Frieboes
Journal:  J Theor Biol       Date:  2017-05-18       Impact factor: 2.691

Review 5.  An "elite hacker": breast tumors exploit the normal microenvironment program to instruct their progression and biological diversity.

Authors:  Aaron Boudreau; Laura J van't Veer; Mina J Bissell
Journal:  Cell Adh Migr       Date:  2012-05-01       Impact factor: 3.405

6.  CLIC4 regulates TGF-β-dependent myofibroblast differentiation to produce a cancer stroma.

Authors:  A Shukla; R Edwards; Y Yang; A Hahn; K Folkers; J Ding; V C Padmakumar; C Cataisson; K S Suh; S H Yuspa
Journal:  Oncogene       Date:  2013-02-18       Impact factor: 9.867

7.  Molecular crosstalk between cancer cells and tumor microenvironment components suggests potential targets for new therapeutic approaches in mobile tongue cancer.

Authors:  Dan Dayan; Tuula Salo; Sirpa Salo; Pia Nyberg; Sini Nurmenniemi; Daniela Elena Costea; Marilena Vered
Journal:  Cancer Med       Date:  2012-08-16       Impact factor: 4.452

8.  Involvement of host stroma cells and tissue fibrosis in pancreatic tumor development in transgenic mice.

Authors:  Itai Spector; Yael Zilberstein; Adi Lavy; Arnon Nagler; Olga Genin; Mark Pines
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

9.  Stromal-epithelial crosstalk provides a suitable microenvironment for the progression of ovarian cancer cells in vitro.

Authors:  Shilong Fu; Lihua Dong; Wei Sun; Yi Xu; Li Gao; Yi Miao
Journal:  Cancer Invest       Date:  2013-10-22       Impact factor: 2.176

10.  High expression of IGFBP7 in fibroblasts induced by colorectal cancer cells is co-regulated by TGF-β and Wnt signaling in a Smad2/3-Dvl2/3-dependent manner.

Authors:  Cui Rao; Shan-Li Lin; Wen-Jing Ruan; Huan Wen; Dan-Ju Wu; Hong Deng
Journal:  PLoS One       Date:  2014-01-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.